<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01551784</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-CSE-CRE-2011/1</org_study_id>
    <nct_id>NCT01551784</nct_id>
  </id_info>
  <brief_title>An Observational Study of Statin Treatment Induced HDL Changes</brief_title>
  <acronym>SIRIUS</acronym>
  <official_title>An Observational Study of Statin Treatment Induced HDL Changes - Effect on Cardiovascular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim with this study is to investigate the effect of statin induced changes in HDL-C on
      all cause mortality and CVD with adjustment for changes in other blood lipids and clinical
      parameters in Sweden, UK and the Netherlands.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An observational study of statin treatment induced HDL changes - effect on cardiovascular
      disease
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first occurrence of hospitalization for acute myocardial infarction, unstable angina pectoris or ischemic stroke related to changes in HDL-C</measure>
    <time_frame>1st of January 2004 to 31st December 2010</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The effect of statin induced changes in HDL-C (per mmol/L) on a composite endpoint including unstable angina pectoris, myocardial infarction, ischemic stroke and all cause mortality.</measure>
    <time_frame>1st of January 2004 to 31st December 2010</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first occurence of hospitalization for acute myocardial infarction, unstable angina pectoris or ischemic stroke and ischemic heart disease mortality related to changes in HDL-C.</measure>
    <time_frame>1st of January 2004 to 31st December 2010</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relationships between acquired HDL levels after statin treatment on the primary endpoint and the effect of HDL increase on the primary endpoint for different levels of baseline HDL</measure>
    <time_frame>1st of January 2004 to 31st December 2010</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potential interactions between baseline HDL and HDL increase and other factors like age, gender, treatment and co-morbidity on the primary endpoint</measure>
    <time_frame>1st of January 2004 to 31st December 2010</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The health economic consequences of increasing HDL-C with statin treatment</measure>
    <time_frame>1st of January 2004 to 31st December 2010</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">120000</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
  </arm_group>
  <biospec_descr>
    <textblock>
      Cholesterol values (HDL-C, LDL-C, TC)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who received a first prescription of a statin (ATC code C10AA) between 1st of
        January 2004 and 31st of December 2010. Swedish data will be extracted from medical records
        and national registers and for UK and the Netherlands from central registers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Started treatment with statins within the observation period (2004-2010)

          -  The patient must have valid baseline and follow-up measurements for HDL-C and LDL-C.

        Exclusion Criteria:

          -  Malignancy Alcohol abuse/alcohol dependence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>86 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunnar Johansson, MD, PROFESSOR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Public Health and Caring Sciences, Family Medicine and Clinical Epidemiology Uppsala University 751 22 Uppsala Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ron Herings, DR, ASSOC PROF</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pharmo Institute for Drug Outcomes Research3508 AE UtrechtThe Netherlands</affiliation>
  </overall_official>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2012</study_first_submitted>
  <study_first_submitted_qc>March 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2012</study_first_posted>
  <last_update_submitted>October 14, 2013</last_update_submitted>
  <last_update_submitted_qc>October 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Statin treatment</keyword>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Statin treatment induced HDL changes and the effect on cardiovascular disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

